Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
- Language: English
- 172 Pages
- Published: July 2012
Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports
Each Pipeline Report provides the user with real detail on a company’s pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company’s product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company’s deals and alliances and recent corporate news including key milestones.
Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company’s research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Product Pipeline Reports
Selected Financial Data
Product Glance (Table/Graph)
Disease Hub Classification (Table/Graph)
Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc.
Patent Details (if any)
Deals & Alliances